APA (7th ed.) Citation

J, B., J, C., L, S., P, G., JF, H., M, L., . . . A, G. (2021). D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy. Cancers, 13(14), . https://doi.org/10.3390/cancers13143622

Chicago Style (17th ed.) Citation

J, Barra, et al. "D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant P53 Counteracting AKT Signaling and Tumor Malignancy." Cancers 13, no. 14 (2021). https://doi.org/10.3390/cancers13143622.

MLA (9th ed.) Citation

J, Barra, et al. "D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant P53 Counteracting AKT Signaling and Tumor Malignancy." Cancers, vol. 13, no. 14, 2021, https://doi.org/10.3390/cancers13143622.